Home / Subjects / Urology

Urology

The branch of medicine focused on the urinary tract and male reproductive system.

โœ“ Introduction to Urology

โœ“ Introduction to Urology is a clinical topic covering pathophysiology, diagnosis, evidence-based treatment, and patient care.

Key points: Core principles, practical applications, and advanced concepts that build deep understanding.

โœ“ Kidney Anatomy Basics

โœ“ Kidney Anatomy Basics is an essential biology topic covering living systems, from cellular processes to ecosystems.

Key points: Structure and function, clinical presentation, diagnostic criteria, and evidence-based management.

โœ“ Bladder Anatomy Basics

โœ“ Bladder Anatomy Basics is an essential biology topic covering living systems, from cellular processes to ecosystems.

Key points: Structure and function, clinical presentation, diagnostic criteria, and evidence-based management.

โœ“ Prostate Anatomy Basics

โœ“ Prostate Anatomy Basics is an essential biology topic covering living systems, from cellular processes to ecosystems.

Key points: Structure and function, clinical presentation, diagnostic criteria, and evidence-based management.

โœ“ Urinalysis Basics

โœ“ Urinalysis Basics is a clinical topic covering pathophysiology, diagnosis, evidence-based treatment, and patient care.

Key points: Core principles, practical applications, and advanced concepts that build deep understanding.

โœ“ UTI Basics

โœ“ UTI Basics is a clinical topic covering pathophysiology, diagnosis, evidence-based treatment, and patient care.

Key points: Core principles, practical applications, and advanced concepts that build deep understanding.

โœ“ Kidney Stones Basics

โœ“ Kidney Stones Basics is a clinical topic covering pathophysiology, diagnosis, evidence-based treatment, and patient care.

Key points: Core principles, practical applications, and advanced concepts that build deep understanding.

โœ“ Hematuria Basics

โœ“ Hematuria Basics is a clinical topic covering pathophysiology, diagnosis, evidence-based treatment, and patient care.

Key points: Core principles, practical applications, and advanced concepts that build deep understanding.

โœ“ BPH Basics

โœ“ BPH Basics is a clinical topic covering pathophysiology, diagnosis, evidence-based treatment, and patient care.

Key points: Core principles, practical applications, and advanced concepts that build deep understanding.

โœ“ Prostate Cancer Basics

โœ“ Prostate Cancer Basics is a clinical topic covering pathophysiology, diagnosis, evidence-based treatment, and patient care.

Key points: Core principles, practical applications, and advanced concepts that build deep understanding.

โœ“ Bladder Cancer Basics

โœ“ Bladder Cancer Basics is a clinical topic covering pathophysiology, diagnosis, evidence-based treatment, and patient care.

Key points: Core principles, practical applications, and advanced concepts that build deep understanding.

โœ“ Erectile Dysfunction Basics

โœ“ Erectile Dysfunction Basics is a core mathematics topic covering definitions, formulas, and problem-solving techniques essential for mastery.

Key points: Formal definition, derivation, worked examples, and common applications with step-by-step solutions.

โœ“ Male Infertility Basics

โœ“ Male Infertility Basics is a clinical topic covering pathophysiology, diagnosis, evidence-based treatment, and patient care.

Key points: Core principles, practical applications, and advanced concepts that build deep understanding.

โœ“ Incontinence Basics

โœ“ Incontinence Basics is a clinical topic covering pathophysiology, diagnosis, evidence-based treatment, and patient care.

Key points: Core principles, practical applications, and advanced concepts that build deep understanding.

โœ“ Urology Ethics Basics

โœ“ Urology Ethics Basics is a clinical topic covering pathophysiology, diagnosis, evidence-based treatment, and patient care.

Key points: Core principles, practical applications, and advanced concepts that build deep understanding.

โœ“ Urology Careers

โœ“ Urology Careers is a clinical topic covering pathophysiology, diagnosis, evidence-based treatment, and patient care.

Key points: Core principles, practical applications, and advanced concepts that build deep understanding.

โœ“ Advanced Urology

โœ“ Advanced Urology is a clinical topic covering pathophysiology, diagnosis, evidence-based treatment, and patient care.

Key points: Core principles, practical applications, and advanced concepts that build deep understanding.

โœ“ Kidney Anatomy

โœ“ Kidney Anatomy is an essential biology topic covering living systems, from cellular processes to ecosystems.

Key points: Structure and function, clinical presentation, diagnostic criteria, and evidence-based management.

โœ“ Bladder Anatomy

โœ“ Bladder Anatomy is an essential biology topic covering living systems, from cellular processes to ecosystems.

Key points: Structure and function, clinical presentation, diagnostic criteria, and evidence-based management.

โœ“ Prostate Anatomy

โœ“ Prostate Anatomy is an essential biology topic covering living systems, from cellular processes to ecosystems.

Key points: Structure and function, clinical presentation, diagnostic criteria, and evidence-based management.

โœ“ Urinalysis

โœ“ Urinalysis is a clinical topic covering pathophysiology, diagnosis, evidence-based treatment, and patient care.

Key points: Core principles, practical applications, and advanced concepts that build deep understanding.

โœ“ UTI

โœ“ UTI is a clinical topic covering pathophysiology, diagnosis, evidence-based treatment, and patient care.

Key points: Core principles, practical applications, and advanced concepts that build deep understanding.

โœ“ Kidney Stones

โœ“ Kidney Stones is a clinical topic covering pathophysiology, diagnosis, evidence-based treatment, and patient care.

Key points: Core principles, practical applications, and advanced concepts that build deep understanding.

โœ“ Hematuria

โœ“ Hematuria is a clinical topic covering pathophysiology, diagnosis, evidence-based treatment, and patient care.

Key points: Core principles, practical applications, and advanced concepts that build deep understanding.

โœ“ BPH

โœ“ BPH is a clinical topic covering pathophysiology, diagnosis, evidence-based treatment, and patient care.

Key points: Core principles, practical applications, and advanced concepts that build deep understanding.

โœ“ Prostate Cancer

โœ“ Prostate Cancer is a clinical topic covering pathophysiology, diagnosis, evidence-based treatment, and patient care.

Key points: Core principles, practical applications, and advanced concepts that build deep understanding.

โœ“ Bladder Cancer

โœ“ Bladder Cancer is a clinical topic covering pathophysiology, diagnosis, evidence-based treatment, and patient care.

Key points: Core principles, practical applications, and advanced concepts that build deep understanding.

โœ“ Erectile Dysfunction

โœ“ Erectile Dysfunction is a core mathematics topic covering definitions, formulas, and problem-solving techniques essential for mastery.

Key points: Formal definition, derivation, worked examples, and common applications with step-by-step solutions.

โœ“ Male Infertility

โœ“ Male Infertility is a clinical topic covering pathophysiology, diagnosis, evidence-based treatment, and patient care.

Key points: Core principles, practical applications, and advanced concepts that build deep understanding.

โœ“ Incontinence

โœ“ Incontinence is a clinical topic covering pathophysiology, diagnosis, evidence-based treatment, and patient care.

Key points: Core principles, practical applications, and advanced concepts that build deep understanding.

โœ“ Urology Ethics

โœ“ Urology Ethics is a clinical topic covering pathophysiology, diagnosis, evidence-based treatment, and patient care.

Key points: Core principles, practical applications, and advanced concepts that build deep understanding.

โœ“ Urology Research

โœ“ Urology Research is a clinical topic covering pathophysiology, diagnosis, evidence-based treatment, and patient care.

Key points: Time complexity (Big-O), space complexity, correctness proof, and practical implementation trade-offs.

Key Clinical Formulas & Scores

International Prostate Symptom Score (IPSS):
7 questions, each scored 0-5 (total 0-35)
1. Incomplete emptying (frequency of sensation of not emptying bladder completely)
2. Frequency (voiding every โ‰ค2 hours)
3. Intermittency (stopping and starting again)
4. Urgency (difficulty postponing voiding)
5. Weak stream
6. Straining to void
7. Nocturia (number of times waking at night to void)
Score: 0-7 = mild, 8-19 = moderate, 20-35 = severe
Plus QoL question: 0-6 (delighted to terrible)
Gleason Score (Prostate Cancer Grading):
Biopsy: primary pattern + secondary pattern (each graded 1-5)
Grade Group 1: Gleason โ‰ค6 (3+3) โ€” low risk
Grade Group 2: Gleason 3+4=7 โ€” intermediate
Grade Group 3: Gleason 4+3=7 โ€” intermediate-high
Grade Group 4: Gleason 4+4=8 โ€” high risk
Grade Group 5: Gleason 9-10 (4+5, 5+4, 5+5) โ€” very high risk
Gleason 5 = no glandular differentiation (sheets, cords, single cells)
AUA Symptom Index (Benign Prostatic Hyperplasia):
Same as IPSS โ€” measures LUTS severity
Voiding symptoms (obstructive): weak stream, intermittency, straining, incomplete emptying
Storage symptoms (irritative): frequency, urgency, nocturia
Management thresholds: IPSS โ‰ค7 = watchful waiting, 8-19 = medical therapy (ฮฑ-blocker ยฑ 5ฮฑ-reductase inhibitor), โ‰ฅ20 or complications = surgical (TURP, HoLEP)
Prostate Cancer Risk Stratification (NCCN):
Very Low: PSA <10, Gleason โ‰ค6, T1-T2a, <3 positive cores, <50% cancer per core
Low: PSA <10, Gleason โ‰ค6, T1-T2a
Intermediate: PSA 10-20 OR Gleason 7 OR T2b-T2c
Favorable Intermediate: โ‰ค50% cores positive, 1 intermediate factor
Unfavorable Intermediate: >50% cores positive, Gleason 3+4 with pattern 4 >50%, multiple intermediate factors
High: PSA >20 OR Gleason 8-10 OR T3-T4
Very High: T3b-T4, primary Gleason pattern 5, >4 cores with Gleason 8-10
PSA Screening Guidelines:
USPSTF: Individualized decision age 55-69 (Grade C), โ‰ฅ70 not recommended (Grade D)
AUA: Baseline PSA at 40-55 for high risk (African American, family history)
PSA velocity: >0.75 ng/mL/year is concerning
PSA density: PSA/prostate volume >0.15 increases cancer suspicion
Free PSA: % free PSA <10% = higher cancer probability, 10-25% = intermediate, >25% = lower

Core Concepts

Hematuria Evaluation

Gross hematuria: โ‰ฅ3 RBCs/HPF on microscopic or visible blood. Etiologies: infection, stones, BPH, glomerular disease, malignancy, trauma, exercise, drugs. Risk stratification for urothelial carcinoma: High risk โ€” age >40, smoking history >15 pack-years, >25 RBCs/HPF, gross hematuria. Workup: CT urography (gold standard for upper tract), cystoscopy (mandatory), urine cytology. Low risk: <40 years, non-smoker, microscopic only โ€” consider renal ultrasound or repeat UA.

Urinary Tract Infections (UTI)

Uncomplicated cystitis: premenopausal, non-pregnant female. First-line: nitrofurantoin 100mg BID ร— 5 days, TMP-SMX DS BID ร— 3 days (if resistance <20%), fosfomycin 3g single dose. Complicated UTI: male, pregnancy, indwelling catheter, immunocompromised, structural abnormality. Pyelonephritis: fever, flank pain, CVA tenderness. Treatment: outpatient โ€” ciprofloxacin 500mg BID ร— 7 days or levofloxacin 750mg daily ร— 5 days (if local resistance <10%). Inpatient โ€” ceftriaxone or ciprofloxacin IV. Pregnancy: nitrofurantoin (avoid near term), amoxicillin-clavulanate, cephalexin.

Renal Colic & Stone Management

Calcium oxalate (70%), uric acid (10%), struvite (10%), cystine (5%). Non-contrast CT: gold standard. Size matters: <5 mm passes spontaneously (80%), 5-10 mm (medical expulsive therapy with tamsulosin), >10 mm needs intervention. Intervention: ESWL (extracorporeal shock wave lithotripsy) for <2 cm renal or proximal ureteral stones, ureteroscopy with laser lithotripsy, percutaneous nephrolithotomy for >2 cm or staghorn. Struvite stones: treat underlying UTI (Proteus, Klebsiella), may need complete removal.

Clinical Case Studies

Case 1: Elevated PSA and Prostate Cancer

Patient: 68-year-old male, PSA 8.2 ng/mL (previous 2.1 two years ago). No urinary symptoms. DRE: right lobe firm, nodular. PSA velocity = 3.05 ng/mL/year. Free PSA = 12%.

Diagnosis: Elevated PSA, abnormal DRE, low free PSA โ†’ high suspicion for prostate cancer. MRI prostate: PIRADS 5 lesion in right peripheral zone. Targeted + systematic biopsy: Gleason 4+3=7 (Grade Group 3) in 6/12 cores, 80% cancer in positive cores. Bone scan: negative. CT abdomen/pelvis: negative for nodes.

Management: Intermediate-risk (unfavorable). Treatment options: radical prostatectomy (open, laparoscopic, or robotic-assisted) or external beam radiation therapy (IMRT) + androgen deprivation therapy (ADT) for 4-6 months. Active surveillance NOT appropriate. Post-prostatectomy: monitor PSA (undetectable expected), erectile rehabilitation, urinary continence training.

Case 2: Gross Hematuria

Patient: 55-year-old male, painless gross hematuria ร— 2 weeks, clots. 30-pack-year smoker. No dysuria, no flank pain, no weight loss. UA: 200+ RBCs/HPF, no WBCs, no protein. Urine cytology: atypical cells.

Assessment: High risk for urothelial carcinoma (age >40, smoking history, gross hematuria, >25 RBCs/HPF).

Workup: CT urography: 2.5 cm enhancing lesion in right renal pelvis. Cystoscopy: normal bladder mucosa. Diagnosis: upper tract urothelial carcinoma. Treatment: radical nephroureterectomy with bladder cuff excision. Adjuvant chemotherapy based on final pathology (cisplatin-based if eligible). Surveillance: cystoscopy q3 months ร— 2 years, then q6 months, then annually. CT chest/abdomen/pelvis every 6 months ร— 2 years.

Case 3: Acute Urinary Retention

Patient: 75-year-old male, unable to void ร— 12 hours, suprapubic pain, distended bladder. PMH: BPH ร— 5 years, on tamsulosin. Post-void residual: 850 mL. PSA 4.5 ng/mL. Creatinine 1.4 mg/dL (baseline 0.9).

Diagnosis: Acute urinary retention secondary to BPH with post-obstructive diuresis risk.

Management: Immediate urethral catheterization (16-18 Fr Foley, or coude tip if resistance). Drain slowly (clamp after 500-1000 mL to prevent hematuria). Monitor for post-obstructive diuresis (polyuria after relief). Trial without catheter (TWOC) after 2-3 days with ฮฑ-blocker (tamsulosin 0.4mg daily). If recurrent retention or fails TWOC โ†’ TURP (transurethral resection of prostate) or HoLEP (holmium laser enucleation). 5ฮฑ-reductase inhibitor (finasteride 5mg daily) if prostate >30g.

Practice Questions

Q1: A patient has an IPSS score of 22. What severity of LUTS and recommended management?
A: Severe symptoms (20-35). Consider surgical intervention (TURP or HoLEP). If patient prefers medical therapy: combination ฮฑ-blocker + 5ฮฑ-reductase inhibitor. Evaluate for complications (retention, recurrent UTI, bladder stones, renal insufficiency).
Q2: A prostate biopsy shows Gleason 3+4=7 in 40% of one core out of 12 total cores. What NCCN risk group is this?
A: Favorable intermediate risk (Gleason 3+4=7 with โ‰ค50% positive cores and only one intermediate-risk factor). Active surveillance is an option, or definitive treatment (surgery or radiation).
Q3: What is the first-line treatment for uncomplicated UTI in a non-pregnant premenopausal female?
A: Nitrofurantoin 100mg BID ร— 5 days or TMP-SMX DS BID ร— 3 days (if local resistance <20%). Fosfomycin 3g single dose is an alternative. Fluoroquinolones should be reserved for complicated UTIs or allergies.
Q4: What is the gold standard imaging study for evaluating gross hematuria?
A: CT urography (CT with contrast, excretory phase). It visualizes the kidneys, ureters, and bladder. Cystoscopy is also mandatory to evaluate the bladder.
Q5: A 12 mm renal stone in the lower pole. What is the best treatment option?
A: For stones >10 mm, ESWL has lower success rates for lower pole stones. Ureteroscopy with laser lithotripsy (URS) is preferred for 10-20 mm lower pole stones. PCNL is reserved for stones >20 mm or staghorn calculi.

๐Ÿ“š Related Subjects

All Subjects

Categories

Get Premium